Cancer staging considers the size of the tumor, whether it has grown into surrounding lymph nodes and whether it has spread to distant parts of the body (metastasized).
The severity of a breast cancer is evaluated according to a complex system called staging.
"N" represents the spread of the cancer to lymph nodes, largely determined by those nodes removed at surgery that contain cancer cells.
Lung cancer staging involves the placement of the cancer's progression into stages, or levels. These stages help a physician study cancer and provide consistent definition levels of cancer and corresponding treatments.
The staging of breast cancer describes the varying level of the cancer. There are 4 stages and a few of the stages have multiple classifications based on where the cancer is found and it's size.
Seth A. Borg has written: 'Handbook of cancer diagnosis and staging' -- subject(s): Cancer, Diagnosis, Handbooks, manuals, Neoplasm Staging, Neoplasms
In the case of lung cancer staging, results are related to the severity and progression of the cancer.
There are a few standard methods of comparing one cancer to another for the purposes of comparing treatments and estimating outcomes. These methods are called "staging." The most universal method is the TNM system.
Breast cancer staging is based on the size of the tumor, the involvement of lymph nodes and the presence of metastasis (spreading). It can't just be determined by the size until the other factors are evaluated as well. The presence of lymph node involvement is determined at surgery. Surgery should be scheduled within 4 weeks of detecting a tumor
Deslauriers, Jean, and Jocelyn Gregoire. "Clinical and Surgical Staging of Non-Small Cell Lung Cancer." Chest, Supplement (April 2000): 96S-103S.
The International Federation of Gynecology and Obstetrics (FIGO) has adopted a surgical staging system for vulvar cancer.
He was determined because he had cancer and wanted to prove to himself and to the world that he was stronger than his cancer.
"M" refers to the metastases, how far they are from the original cancer and how often they have multiplied.